Brexpiprazole
Brand name: Rexulti
Rank #90 of 500 drugs by total cost
$204.0M
Total Cost
136,378
Total Claims
$204.0M
Total Cost
5,108
Prescribers
$1,496
Cost per Claim
5,124
Beneficiaries
145,776
30-Day Fills
$40K
Avg Cost/Provider
27
Avg Claims/Provider
About Brexpiprazole
Brexpiprazole (sold as Rexulti) was prescribed 136,378 times by 5,108 Medicare Part D providers in 2023, costing the program $204.0M. At $1,496 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 87 | Abatacept (Orencia) | $216.6M | 36,753 |
| 88 | Losartan Potassium (Losartan Potassium) | $213.4M | 14,466,748 |
| 89 | Oxycodone Hcl (Oxycodone Hcl) | $213.2M | 3,537,078 |
| 90 | Brexpiprazole (Rexulti) | $204.0M | 136,378 |
| 91 | Glatiramer Acetate (Copaxone) | $203.6M | 40,986 |
| 92 | Denosumab (Prolia) | $199.4M | 114,710 |
| 93 | Ticagrelor (Brilinta) | $195.8M | 293,897 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology